Form 8-K - Current report:
SEC Accession No. 0001493152-24-034813
Filing Date
2024-09-03
Accepted
2024-09-03 16:05:38
Documents
15
Period of Report
2024-09-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53547
2 ex99-1.htm EX-99.1 375891
3 ex99-2.htm EX-99.2 84776
  Complete submission text file 0001493152-24-034813.txt   743185

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE xtnt-20240903.xsd EX-101.SCH 3027
5 XBRL LABEL FILE xtnt-20240903_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE xtnt-20240903_pre.xml EX-101.PRE 24173
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3620
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 241274034
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)